Hi-Aspect has an experienced management team
and high quality Board.

Management Team

sciencelens_4050 Director Jennifer Anderson (1) (2).jpg

Jennifer Anderson
EXECUTIVE DIRECTOR

Experienced in the commercialisation of biotechnologies and managing StartUps, Jennifer is responsible for the day to day running of the company and managing the research and development programmes that drive the companies new product development agendas.

 
Kelly photo (1).png

Kelly Feterika
NZ GENERAL MANAGER

With a background in skincare sales, including 8 years working for Trilogy Natural Skin care as, the NZ Sales Manager, Kelly is responsible for sales of the New Logic brand in New Zealand, developing the retail education programmes and providing strategic insight into new product development.

 

20190522_134913 (2).jpg

Theresa Donnelly
FINANCIALS & ADMIN

Through her extensive industry experience working for wholesalers and distributors in the retail health industry, Theresa knows the business systems and processes required to run a smooth and efficient office, that is responsive to its customers.

 

The Board

Elizabeth Hopkins Photo (1).png

Elizabeth Hopkins
INDEPENDENT CHAIR

Elizabeth Hopkins is Director of Research and Innovation at Lincoln University, a board member of Innate Therapeutics and deputy chair of the Canterbury Polytechnic Institute of Technology. She is a specialist in scientific commercialisation, and pharmaceutical and biotechnology management and has held senior executive positions with several prominent biotechnology companies in New Zealand and overseas including Keratec, EnCoate and Pfizer in the UK.

Elizabeth was educated at Oxford Brookes University.

Her specialties include all aspects of IP commercialisation from initial investment in research right through to manufacturing and sales of final product.

SIlvey.png

Steve Silvey
DIRECTOR

As an Investment Director at Oxford University and a Chartered Accountant, Steve supports the strategic and financial direction of the company at a board level. Steve brings an excellent understanding of what is required to support a new company in the biotech sector.